Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Free Cash Flow (2017 - 2025)

Selectis Health's Free Cash Flow history spans 14 years, with the latest figure at $275795.0 for Q3 2025.

  • For Q3 2025, Free Cash Flow rose 122.48% year-over-year to $275795.0; the TTM value through Sep 2025 reached $442312.0, up 113.47%, while the annual FY2024 figure was -$1.8 million, 462.24% down from the prior year.
  • Free Cash Flow for Q3 2025 was $275795.0 at Selectis Health, up from -$240894.0 in the prior quarter.
  • Across five years, Free Cash Flow topped out at $2.4 million in Q3 2023 and bottomed at -$1.9 million in Q4 2023.
  • The 5-year median for Free Cash Flow is -$195241.0 (2021), against an average of -$94533.9.
  • The largest annual shift saw Free Cash Flow surged 761.77% in 2022 before it tumbled 508.92% in 2023.
  • A 5-year view of Free Cash Flow shows it stood at $1.3 million in 2021, then plummeted by 65.3% to $453908.0 in 2022, then crashed by 508.92% to -$1.9 million in 2023, then soared by 77.98% to -$408760.0 in 2024, then skyrocketed by 167.47% to $275795.0 in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Free Cash Flow are $275795.0 (Q3 2025), -$240894.0 (Q2 2025), and $816171.0 (Q1 2025).